Adding Taxotere to chemotherapy regimen improves survival in early breast cancer

[News]

For patients with early stage breast cancer that has spread to the lymph nodes, adding four cycles of docetaxel (Taxotere) into a sequential regimen of epirubicin followed by cyclophosphamide, methotrexate and fluorouracil (CMF) reduces the risk of recurrence and death, updated long-term results show.

More... (http://www.news-medical.net/?id=41440)